Federal University of São Paulo
unifesp.brLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
435
Active
25
Phase 3
49
Total enrollment
102,074
Pipeline matrix
Showing 18 of 18 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Platelet-rich fibrin | — | — | — | — | 2 | ||
| Corticosteroid | — | — | — | — | — | 1 | |
| Triple combination formula | — | — | — | — | — | 1 | |
| Bimatoprost .03% sterile ophthalmic solution | — | — | — | — | — | 1 | |
| Midazolam | — | — | — | — | 2 | ||
| Ketamine | — | — | — | — | — | 2 | |
| Gammora® | — | — | — | — | — | 1 | |
| Erythropoietin | — | — | — | — | — | 1 | |
| Maraviroc | — | — | — | — | 2 | ||
| Dolutegravir | — | — | — | — | 2 | ||
| Dendritic Cell Vaccine | — | — | — | — | 2 | ||
| Auranofin | — | — | — | — | 2 | ||
| Sirtuin Histone deacetylase inhibitor | — | — | — | — | 2 | ||
| Bone Marrow Aspirate | — | — | — | — | — | 1 | |
| Tenofovir Disoproxil | — | — | — | — | — | 1 | |
| Estriol | — | — | — | — | — | 1 | |
| Chemical Denervation with Absolute Alcohol | — | — | — | — | — | 1 | |
| Promestriene | — | — | — | — | — | 1 |
Next readouts
- 2024-12-10
- 2024-12-31
- 2025-06-01
- 2025-08
- 2025-09
- 2025-11-01
- 2026-09
- 2027-01-01
- 2027-02-01
- 2027-06-01
Top conditions
- Obesity13
- Fibromyalgia11
- Pain10
- Rheumatoid Arthritis10
- Knee Osteoarthritis8
- Inflammation7
- Physical Activity6
- Acute Coronary Syndrome5
Frequently asked questions about Federal University of São Paulo
- How many clinical trials does Federal University of São Paulo have on ClinicalTrials.gov?
- Federal University of São Paulo is listed as the lead sponsor on 435 clinical trials in ClinicalTrials.gov, 25 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Federal University of São Paulo's trials are in Phase 3?
- 49 of Federal University of São Paulo's trials are in Phase 3, spread across 18 active drug programs.
- What therapeutic areas does Federal University of São Paulo focus on?
- Federal University of São Paulo's most-studied conditions on ClinicalTrials.gov are Obesity, Fibromyalgia, Pain, Rheumatoid Arthritis, Knee Osteoarthritis.
- When are Federal University of São Paulo's next clinical trial readouts?
- Federal University of São Paulo has 10 upcoming primary-completion readouts tracked here; the soonest is “Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma”, expected around 2024-12-10.